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Introduction and Aims:Mineral nanoparticles may directly link inflammatory and
calcification processes that often co-exist in patients with CKD and in other age-related
vascular diseases. Synthetic mineral nanoparticles are strong activators of a
pro-inflammatory response in the macrophage in vitro, inducing interleukin (IL)-1β
secretion via activation of the NOD-like receptor protein-3 (NLRP3) inflammasome.
However, serum-derived mineral nanoparticles, colloidal complexes of insoluble
mineral and mineral-binding proteins, so-called calciprotein particles (CPP), appear
comparatively benign. This implies that mineral-binding proteins such as fetuin-A,
abundant in extracellular fluid and major constituents of native CPP, may regulate the
inflammatory potential of mineral nanoparticles and may thus be a key determinant of
cellular toxicity.
Methods:We studied the ability of amorphous (CPP-I) and crystalline (CPP-II)
serum-derived mineral nanoparticles to prime and activate the NLRP3 inflammasome
in human macrophage derived from peripheral monocytes, and compared this to the
effect of synthetic hydroxyapatite nanocrystals and other known particulate/soluble
inducers of the inflammasome platform.
Results: Although CPP-I were rapidly internalised via class A scavenger
receptor-(SR-A)-mediated endocytosis, they failed to prime or activate the
inflammasome even at high levels. In contrast, exposure of naïve cells to CPP-II,
primed inflammatory cytokine synthesis through Toll-like receptor
(TLR)-mediated/NF-κB-dependent signalling. Priming was potentiated by
immunochemical blockade of the SR-A. Endocytosis of CPP-II resulted in
activation of the NLRP3 inflammasome at very high levels through elevations in
intracellular reactive oxygen species, calcium and cathepsin B release, secondary to
endolysosomal destabilisation. Equivalent loads of synthetic hydroxyapatite
nanocrystals induced greater release of IL-1β from macrophage, portending to a
protective role for mineral-binding proteins in this context. Importantly, fetuin-A
was found to inhibit cathepsin B activity and hence reveals one pathway through
which this mineral-binding protein might limit activation of intracellular danger
sensors and unwanted inflammatory reactions in response to physiologic mineral
debris. Moreover, that CPP-II only activated the inflammasome at levels far
exceeding than those detected in human serum suggests that such endogenous
particulates are unlikely to be potently pro-inflammatory.
Conclusions: Fetuin-A limits mineral nanoparticle activation of the NLRP3
inflammasome. Further work is needed to substantiate the involvement of native
serum-derived mineral nanoparticles in the pathogenesis of inflammatory vascular
disease in vivo.
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